Curanex Pharmaceuticals CURX
NASDAQ CURX
$5.05 +0.12 (+2.43%)
At close: Sep 30, 2026 · 4:00 PM EDT

Curanex Pharmaceuticals (CURX) EBIT (2024 - 2026)

Updated

Curanex Pharmaceuticals' EBIT was -$3.33 million in Q2 2026, compared with -$57,658 a year earlier.

Analysis

Curanex Pharmaceuticals (CURX) EBIT (2024 - 2026) Analysis & Trends

On a trailing twelve-month basis, Curanex Pharmaceuticals' EBIT was -$7.43 million through Jun 30, 2026; for FY2025, it was -$4.24 million.

  • In earlier years, EBIT was -$365,062 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 7.14 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 6.43 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -584.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 4.75 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 3.16 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 3.51 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -10.39 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.27 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Curanex Pharmaceuticals 7.16 Mn -6.69 Mn - -3.33 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.33 Mn
Dec 31, 2025 -3.09 Mn
Sep 30, 2025 -951,327.00
Jun 30, 2025 -57,658.00
Dec 31, 2024 -147,366.00
Sep 30, 2024 -93,295.00
API Access

Curanex Pharmaceuticals EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=CURX&period=max&api_key=YOUR_API_KEY